Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Alcovit is an oral dietary supplement marketed by CDM Medical for hangover prevention and reduction of blood alcohol concentration after alcohol consumption. The product is described as a lime-flavored effervescent powder whose principal active component is clinoptilolite zeolite, a natural mineral silicate sourced from South Africa and milled in Germany under GMP standards, together with added vitamins, minerals, folic acid, and natural chlorophyll. Its proposed mechanism is physical adsorption of ethanol within the stomach and small intestine, thereby limiting systemic absorption and promoting gastrointestinal elimination rather than acting through a conventional receptor-mediated pharmacology. Publicly described use cases include hangover prevention and liver detoxification, and clinical evaluation has been reported in healthy adults for reduction of blood alcohol concentration.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Alcovit.